Search research articles
Contact Us
Filters
Showing results (31-40 of 83) with videos related to
Page
of 9
Sort By:
Journal of Managed Care & Specialty Pharmacy
|
June 26, 2020
Preclinical Alzheimer Disease Drug Development: Early Considerations Based on Phase 3 Clinical Trials
Anna Hung, Monika Schneider, Marianne Hamilton Lopez, et al.
The American Journal of Managed Care
|
March 18, 2020
Cost-effectiveness of diabetes treatment sequences to inform step therapy policies
Anna Hung, Bhavna Jois, Amy Lugo, et al.
Plos One
|
January 19, 2023
Impact of list price changes on out-of-pocket costs and adherence in four high-rebate specialty drugs
William Bruce Wong, Arpamas Seetasith, Anna Hung, et al.
Journal of Managed Care & Specialty Pharmacy
|
November 30, 2020
Prescribing rates and characteristics of recipients of tenofovir-containing regimens before and after market entry of tenofovir alafenamide
Anna Hung, Matthew Sinclair, Marion Hemmersbach-Miller, et al.
Archives of Physical Medicine and Rehabilitation
|
March 10, 2021
Physical Therapy Use, Costs, and Value for Latent Classes of Good vs Poor Outcome in Patients Who Catastrophize About Their Pain Prior to Knee Arthroplasty
Christine M Orndahl, Robert A Perera, Anna Hung, et al.
Ophthalmology. Glaucoma
|
January 27, 2023
Cost-Utility Analysis of a Medication Adherence-Enhancing Educational Intervention for Glaucoma
Anna Hung, Andrew M Williams, Paula Anne Newman-Casey, et al.
Contemporary Clinical Trials Communications
|
July 21, 2020
Site engagement for multi-site clinical trials
Dana Goodlett, Anna Hung, Ashley Feriozzi, et al.
The Oncologist
|
April 30, 2016
Patterns of Biologics Use Across Treatment Lines in Elderly (Age >65) Medicare Patients With Metastatic Colon Cancer
Kaloyan A Bikov, C Daniel Mullins, Anna Hung, et al.
Journal of Managed Care & Specialty Pharmacy
|
February 4, 2020
Risk Factors and Outcomes of Opioid Users with and Without Concurrent Benzodiazepine Use in the North Carolina Medicaid Population
Anna Hung, Christopher Bush, Melissa Greiner, et al.
Journal of Managed Care & Specialty Pharmacy
|
March 1, 2019
Using a Budget Impact Model Framework to Evaluate Antidiabetic Formulary Changes and Utilization Management Tools
Anna Hung, C Daniel Mullins, Julia F Slejko, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 83) with videos related to
Sort By:
Page
of 9
Journal of Managed Care & Specialty Pharmacy
|
June 26, 2020
Preclinical Alzheimer Disease Drug Development: Early Considerations Based on Phase 3 Clinical Trials
Anna Hung, Monika Schneider, Marianne Hamilton Lopez, et al.
The American Journal of Managed Care
|
March 18, 2020
Cost-effectiveness of diabetes treatment sequences to inform step therapy policies
Anna Hung, Bhavna Jois, Amy Lugo, et al.
Plos One
|
January 19, 2023
Impact of list price changes on out-of-pocket costs and adherence in four high-rebate specialty drugs
William Bruce Wong, Arpamas Seetasith, Anna Hung, et al.
Journal of Managed Care & Specialty Pharmacy
|
November 30, 2020
Prescribing rates and characteristics of recipients of tenofovir-containing regimens before and after market entry of tenofovir alafenamide
Anna Hung, Matthew Sinclair, Marion Hemmersbach-Miller, et al.
Archives of Physical Medicine and Rehabilitation
|
March 10, 2021
Physical Therapy Use, Costs, and Value for Latent Classes of Good vs Poor Outcome in Patients Who Catastrophize About Their Pain Prior to Knee Arthroplasty
Christine M Orndahl, Robert A Perera, Anna Hung, et al.
Ophthalmology. Glaucoma
|
January 27, 2023
Cost-Utility Analysis of a Medication Adherence-Enhancing Educational Intervention for Glaucoma
Anna Hung, Andrew M Williams, Paula Anne Newman-Casey, et al.
Contemporary Clinical Trials Communications
|
July 21, 2020
Site engagement for multi-site clinical trials
Dana Goodlett, Anna Hung, Ashley Feriozzi, et al.
The Oncologist
|
April 30, 2016
Patterns of Biologics Use Across Treatment Lines in Elderly (Age >65) Medicare Patients With Metastatic Colon Cancer
Kaloyan A Bikov, C Daniel Mullins, Anna Hung, et al.
Journal of Managed Care & Specialty Pharmacy
|
February 4, 2020
Risk Factors and Outcomes of Opioid Users with and Without Concurrent Benzodiazepine Use in the North Carolina Medicaid Population
Anna Hung, Christopher Bush, Melissa Greiner, et al.
Journal of Managed Care & Specialty Pharmacy
|
March 1, 2019
Using a Budget Impact Model Framework to Evaluate Antidiabetic Formulary Changes and Utilization Management Tools
Anna Hung, C Daniel Mullins, Julia F Slejko, et al.
Page
of 9